Tilray (TLRY) PT Raised to $23 at Cowen

Cowen analyst Vivien Azer raised the price target on Tilray (NASDAQ: TLRY) to $23.00 (from $20.00) while maintaining an Outperform rating.

The analyst commented, "We are taking down our revenue and EBITDA estimates for TLRY, as we expect COVID challenges in Canada to remain a headwind. In addition, TLRY faces tough market share comps, where it has retraced from peak levels. However, we look for market share to stabilize following the completion of the merger with APHA. Maintain Outperform."

You May Also Be Interested In

• Paychex (PAYX) PT Lowered to $105 at TD Cowen
• Piper Sandler on Park National (PRK): 'Upbeat Commentary & Well-Positioned to Maintain Premium Valuation'
• Zscaler (ZS) PT Raised to $236 at RBC Capital